former interim CEO · KORU Medical Systems, Inc. (KRMD)

James Beck

FY2021 is the first fiscal year CompBrief holds for James Beck as a named executive officer of KORU Medical Systems; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$325,191

Salary $113,593Stock awards $0Bonus $97,636

3rd of 5 named executive officers at Koru Medical Systems by FY2021 total.

5 named officers on file for KORU Medical Systems, FY2021

James Beck’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how KORU Medical Systems’s whole pay program stands against its peers

  • KORU Medical Systems’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on KRMD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 18, 2022 (DEF 14A).

Free

Get James Beck’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

James Beck compensation by year

KORU Medical Systems Summary Compensation Table · the one fiscal year held
In US dollars, as KORU Medical Systems reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$113,593
Bonus$97,636
Stock awards$0
Option awards$0
Non-equity incentive$0
Pension and deferred compensation$0
All other$113,962
Total$325,191

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: KORU Medical Systems, Inc. DEF 14A filed March 18, 2022, accession 0001161697-22-000140, and prior-year filings. Open the filing on EDGAR.

How this page was built: the KORU Medical Systems, Inc. filed document, accession 0001161697-22-000140. Every figure is read from that document and cited to the page and table it appears in. Filed March 18, 2022.

KORU Medical Systems’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Linda TharbyPresident & CEO$725,169
Donald Pettigrewformer President & CEO$351,923
James Beck · this pageformer interim CEO$325,191
Karen FisherChief Financial Officer$297,994
Manuel MarquesChief Operating Officer$260,249

Board service

KORU Medical Systems board · FY2021–FY2022
Director compensation in US dollars, as KORU Medical Systems reports it. Most recent year first; a dash means the company reported no figure in that column.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2022$61,500$60,000—$0$121,500
FY2021$38,841$33,682—$0$72,523

Each year as the company reported it in KORU Medical Systems's director compensation table. Totals are the company's own disclosed totals.

How this board is paid

Company policy: KORU Medical Systems pays directors a $50,000 cash retainer and $60,000 in Common Stock. As stated in KORU Medical Systems's FY2025 proxy.

The full KORU Medical Systems compensation record

free company brief

This page is one person within KORU Medical Systems's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are KORU Medical Systems's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

James Beck's compensation dossier · One-time report. No refunds.